Patient presents with reported statin intolerance, characterized by symptoms consistent with muscle-related adverse effects.  The patient reports experiencing myalgia, muscle aches, or muscle weakness after initiating statin therapy with [statin name and dosage].  Onset of symptoms occurred [timeframe] after starting the medication.  Symptoms severity is described as [mild, moderate, or severe] and [intermittent or constant].  Patient denies any other contributing factors such as strenuous exercise, trauma, or other medications known to cause myopathy.  Creatine kinase (CK) levels were measured and found to be [CK level with units] (normal range: [normal range with units]).  Previous statin use included [list previous statins, dosages, and durations of use].  Due to the reported muscle symptoms and [mention CK levels if elevated, or temporal relationship to statin initiation if CK is normal], a diagnosis of statin intolerance is made.  The statin has been discontinued.  Alternative lipid-lowering therapies will be considered, such as [list specific medications or therapeutic approaches e.g., bile acid sequestrants, ezetimibe, lifestyle modifications]. Patient education was provided regarding the importance of cholesterol management and the potential benefits and risks of alternative therapies.  Follow-up appointment scheduled in [timeframe] to reassess lipid profile and monitor for symptom resolution.  Differential diagnosis includes other causes of myalgia such as hypothyroidism, vitamin D deficiency, and drug-induced myopathy.  ICD-10 code: T46.5X5A (Adverse effect of statins).